Amid a corporate review of AstraZeneca’s global manufacturing and supply network, the company’s Indian subsidiary is planning to close up shop at the “beating heart” of its India operations in ...
Staff secured an "improved pay deal", worth 12.3% over three years, after walkouts began in mid-May.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results